Elevance Health outlines medium term targets, shares sit near S&P 500 insurer peers

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 11:09.

Elevance Health (US2855211023) trades on the NYSE as a major S&P 500 managed care name under the ticker ELV. Consensus estimates and valuation metrics remain central for analysts monitoring the stock alongside peers like UnitedHealth and CVS Health, according to current market data MarketBeat earnings overview.

What analysts expect for Elevance

Street models compiled by several data providers project continued revenue growth for Elevance through 2025, reflecting premium increases and membership trends in US health plans MarketBeat earnings overview. The company remains covered by major Wall Street houses, with most ratings clustered in the Buy and Hold range across the managed care sector TipRanks consensus snapshot.

Consensus earnings estimates factor in Elevance’s efficiency programs, digitalization efforts and medical cost trends in commercial and government plans MarketBeat earnings overview. Analysts also track regulatory developments around Medicare and Medicaid reimbursement, which can influence long term margin assumptions in their models Financial Times managed care analysis.

Where Elevance shares stand now

Elevance shares last closed at 394.98 US dollars on the NYSE on 2026-06-22, implying a modest daily gain of 1.67 percent according to quote data MarketBeat ELV news and quote. At that level, the stock’s market capitalization sits around the upper tier of US managed care names, broadly comparable in scale to other national health insurers Wall Street Journal quote page.

Based on the latest closing price, valuation multiples such as the forward price-earnings ratio for Elevance remain in a corridor typical for S&P 500 health insurers, reflecting a balance of growth and regulatory risk in the sector Wall Street Journal quote page. Investors also watch dividend policy and share repurchases, which influence total shareholder return assumptions alongside earnings growth Financial Times managed care analysis.

How Elevance earns its money

Elevance generates most of its revenue from health insurance premiums and related services under brands such as Anthem Blue Cross Blue Shield in various US states, covering commercial, Medicare and Medicaid members Elevance Health business overview. Additional income streams come from pharmacy benefit management, care delivery and analytics solutions for employers and public programs Elevance Health business overview.

Where the Elevance shares trade

The Elevance Health shares (US2855211023) traded on 2026-06-22 at 394.98 US dollars on the NYSE at 21:59 CET based on the latest available closing data.

This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Figures and estimates are based on sources cited and may change without notice.